UPAYA NOVARTIS DALAM MEMPEROLEH HAK PATEN OBAT GLIVEC DI INDIA
The Glivec's patent case became one of the disputes regarding IPR ownership in India after TRIPS came into effect in 1995. It took 10 years for India to revise the Patent Law in its country to fully comply with TRIPS. The Novartis application case began to be reviewed in 2005 and in 2006 the In...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2022-09-19.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!